Literature DB >> 727809

Immunological events in acute measles influencing outcome.

H M Coovadia, A Wesley, P Brain.   

Abstract

77% of 30 children with measles who had severe lymphopenia (less than 2000/mm3; less than 2.0 x 10(9)/1) within 2 days of appearance of rash (group A) subsequently died or progressed to chronic chest disease. This was significantly worse than the outcome in 30 children with measles who had lymphocyte counts more than 2000/mm3 (more than 2.0 x 10(9)/1) (group B) of whom 67% recovered. In group A children the persistence of severe lymphopenia (caused by a reduction in T- and B-cells) for at least 15 days after onset of rash, remained a good predictive index of morbidity and mortality. Reversal of immunoparesis in group A was slower and incomplete 42 days from appearance of the rash in those who subsequently died or developed chronic chest disease compared with those who recovered. All patients who died failed to produce adequate measles antibodies. The therapeutic implications and immunopathological significance of these findings for chronic complications after acute measles are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727809      PMCID: PMC1545280          DOI: 10.1136/adc.53.11.861

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  EFFECTS OF MEASLES, GAMMA-GLOBULIN-MODIFIED MEASLES AND VACCINE MEASLES ON THE TUBERCULIN TEST.

Authors:  S STARR; S BERKOVICH
Journal:  N Engl J Med       Date:  1964-02-20       Impact factor: 91.245

2.  Persistent measles infection in malnourished children.

Authors:  J Dossetor; H C Whittle; B M Greenwood
Journal:  Br Med J       Date:  1977-06-25

3.  T and B rosetting lymphocytes in the blood of smallpox patients.

Authors:  T M Jackson; S N Zaman; F Huq
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

4.  The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity.

Authors:  H F McFarland
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

5.  Lymphocytopenia: its causes and significance.

Authors:  L R Zacharski; J W Linman
Journal:  Mayo Clin Proc       Date:  1971-03       Impact factor: 7.616

6.  Interaction between papova-like virus and paramyxovirus in human brain cells: a hypothesis.

Authors:  H Koprowski; G Barbanti-Brodano; M Katz
Journal:  Nature       Date:  1970-03-14       Impact factor: 49.962

7.  Persistence of measles virus and depression of antibody formation in patients with giant-cell pneumonia after measles.

Authors:  A MITUS; J F ENDERS; J M CRAIG; A HOLLOWAY
Journal:  N Engl J Med       Date:  1959-10-29       Impact factor: 91.245

8.  Immunoparesis and outcome in measles.

Authors:  H M Coovadia; A Wesley; P Brain; L G Henderson; A F Hallett; G H Vos
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

9.  Alterations in immune responsiveness in acute measles and chronic post-measles chest disease.

Authors:  H M Coovadia; A Wesley; L G Henderson; P Brain; G H Vos; A F Hallett
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

10.  Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.

Authors:  J F Modlin; J T Jabbour; J J Witte; N A Halsey
Journal:  Pediatrics       Date:  1977-04       Impact factor: 7.124

View more
  6 in total

1.  Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly.

Authors:  S N Manié; S de Breyne; S Debreyne; S Vincent; D Gerlier
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A controlled trial of treatment of acquired immunodeficiency in severe measles with thymic humoral factor.

Authors:  D W Beatty; Z T Handzel; M Pecht; C R Ryder; J Hughes; K McCabe; N Trainin
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

3.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

4.  Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.

Authors:  Zaza M Ndhlovu; Monika Angenendt; Diana Heckel; Jonathan P Schneck; Diane E Griffin; Mathias Oelke
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

5.  Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected].

Authors:  MariCarmen Colomar; Irene Puga; Maite López; Marta Massot; Juan I Jorquera; Manuel Reina; Senen Vilaró; Enric Espel
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

6.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.